Universe Pharmaceuticals (UPC) Notes Payables (2020 - 2025)

Universe Pharmaceuticals has disclosed Notes Payables across 6 years of filings, most recently posting $7.1 billion for Q3 2025.

• Notes Payables for Q3 2025 came in at $7.1 billion, up 22.08% year-over-year; the trailing twelve-month figure through Sep 2025 was $7.1 billion (up 22.08% YoY), and the FY2025 annual result was $7.1 billion, up 22.08% from the prior year.
• Notes Payables came in at $7.1 billion for Q3 2025 at Universe Pharmaceuticals, up from $5.9 billion in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $7.1 billion in Q3 2025 to a low of $3.9 million in Q3 2022.
• The 5-year median for Notes Payables is $4.4 million (2022), against an average of $1.6 billion.
• Across the five-year window, Notes Payables slumped 100.0% in 2021 and surged 106726.27% in 2024, its largest moves.
• Universe Pharmaceuticals' Notes Payables stood at $4.3 million in 2021, then fell by 9.19% to $3.9 million in 2022, then surged by 39.28% to $5.5 million in 2023, then soared by 106726.27% to $5.9 billion in 2024, then grew by 22.08% to $7.1 billion in 2025.
• The last three Notes Payables figures came in at $7.1 billion (Q3 2025), $5.9 billion (Q3 2024), and $4.4 million (Q1 2024), per Business Quant data.